<DOC>
	<DOC>NCT00561184</DOC>
	<brief_summary>To assess persistence of antibody titers 17-18 months after primary immunization with two 0.5mL intramuscular (IM) doses of H5N1 influenza vaccine containing H5N1 influenza antigen, as measured by Hemagglutination Inhibition (HI), Single Radial Hemolysis (SRH), and Microneutralization (MN) test</brief_summary>
	<brief_title>Safety and Immunogenicity of a Booster Dose of -H5N1 Influenza Vaccine</brief_title>
	<detailed_description />
	<mesh_term>Influenza, Human</mesh_term>
	<mesh_term>Influenza in Birds</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Healthy subjects who previously participated in study V87P1, but did not receive the booster dose on day 202 Pregnant or breastfeeding Receipt of another vaccine or any investigational agent within the past 4 weeks Surgery planned during the study period</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>H5N1 Pandemic</keyword>
</DOC>